Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Schepers

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
NPJ Regenerative Medicine|December 5, 2018
The impact of immune response on endochondral bone regenerationA Longoni, L Knežević, K Schepers, et al.
Epidemiology and Infection|July 28, 2015
Implementation of latent tuberculosis screening in HIV care centres: evaluation in a low tuberculosis incidence settingC Wyndham-Thomas, K Schepers, V Dirix, et al.
BMC Infectious Diseases|February 2, 2017
Report of three imported cases of neurocysticercosis in GuadeloupeR Blaizot, B Melot, K Schepers, et al.
Progress in Clinical and Biological Research|January 1, 1992
The combined use of elutriation and CD8/magnetic bead separation to engineer the bone marrow allograftS J Noga, J M Davis, G B Vogelsang, et al.
Transplantation Proceedings|February 1, 1997
CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidityS J Noga, G B Vogelsang, A Seber, et al.
Clinical and Vaccine Immunology : CVI|October 25, 2013
Long-incubation-time gamma interferon release assays in response to purified protein derivative, ESAT-6, and/or CFP-10 for the diagnosis of Mycobacterium tuberculosis infection in childrenK Schepers, F Mouchet, V Dirix, et al.
Bone Marrow Transplantation|August 28, 1998
Chemotherapy does not nullify the ability of donor lymphocyte infusions to mediate graft-versus-host reactionsE J Fuchs, A Seber, V Altomonte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activationE M Jaffee, R H Hruban, B Biedrzycki, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
NPJ Regenerative Medicine|December 5, 2018
The impact of immune response on endochondral bone regenerationA Longoni, L Knežević, K Schepers, et al.
Epidemiology and Infection|July 28, 2015
Implementation of latent tuberculosis screening in HIV care centres: evaluation in a low tuberculosis incidence settingC Wyndham-Thomas, K Schepers, V Dirix, et al.
BMC Infectious Diseases|February 2, 2017
Report of three imported cases of neurocysticercosis in GuadeloupeR Blaizot, B Melot, K Schepers, et al.
Progress in Clinical and Biological Research|January 1, 1992
The combined use of elutriation and CD8/magnetic bead separation to engineer the bone marrow allograftS J Noga, J M Davis, G B Vogelsang, et al.
Transplantation Proceedings|February 1, 1997
CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidityS J Noga, G B Vogelsang, A Seber, et al.
Clinical and Vaccine Immunology : CVI|October 25, 2013
Long-incubation-time gamma interferon release assays in response to purified protein derivative, ESAT-6, and/or CFP-10 for the diagnosis of Mycobacterium tuberculosis infection in childrenK Schepers, F Mouchet, V Dirix, et al.
Bone Marrow Transplantation|August 28, 1998
Chemotherapy does not nullify the ability of donor lymphocyte infusions to mediate graft-versus-host reactionsE J Fuchs, A Seber, V Altomonte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activationE M Jaffee, R H Hruban, B Biedrzycki, et al.
Pageof 2